Skip to main content

Nancyclotep

The new medical imaging platform in University Hospital of Nancy

nancyclotep, imigine, pmb

Founded in 2007, Nancyclotep develops and offers solutions ranging from R&D to clinical studies and production, enabling, to meet the needs for transferring radiopharmaceuticals to the clinical setting.

Nancyclotep features state-of-the-art facilities including a radiochemistry and radiopharmacy laboratory, a preclinical studies platform, an industrial production laboratory, 3 PET-scans, an e-learning laboratory offering innovative solutions and a hospital environment providing immediate access to both medical expertise and patients for technological applications for clinical use.

Read more

Overview

Situated on the site of the University Hospital of Nancy (France), Nancyclotep features:

  • a hospital environment providing immediate access to both high-caliber medical expertise as well as to patients for technological applications for clinical use
     
  • state-of-the-art equipment combined with a radiochemistry and radiopharmacy laboratory, a platform for pre-clinical studies, an industrial production laboratory, a high-quality imaging fleet
     
  • an e-learning laboratory offering innovative solutions
Nancyclotep_TEP-scan_CHRU_Nancy

Partnership with PMB

PMB-ALCEN and Nancyclotep join forces to meet the challenges of tomorrow's healthcare and nuclear medicine to:

  • promote the research and development of new molecules of clinical interest
  • improve and optimize iMiGiNE's industrial processes and operations in a hospital environment
  • participate in the transition from conventional to personalized medicine, specifically for companion tests related to targeted treatments
Nancylotep-radiochimie-Nancy